These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7093209)

  • 1. Circular dichroism and nuclear magnetic resonance studies on the complexation of valinomycin with calcium.
    Vishwanath CK; Easwaran KR
    Biochemistry; 1982 May; 21(11):2612-21. PubMed ID: 7093209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution conformations of valinomycin-divalent cation complexes.
    Sankaram MB; Easwaran KR
    Int J Pept Protein Res; 1985 Jun; 25(6):585-93. PubMed ID: 4030216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational studies on calcium binding by tBoc-Leu-Pro-Tyr-Ala-NHCH3, a tyrosine kinase substrate, in a nonpolar solvent.
    Ananthanarayanan VS; Saint-Jean A; Cheesman BV; Hughes DW; Bain AD
    J Biomol Struct Dyn; 1993 Dec; 11(3):509-28. PubMed ID: 8129870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR evidence of a valinomycin-proton complex.
    Kríz J; Makrlík E; Vanura P
    Biopolymers; 2006 Feb; 81(2):104-9. PubMed ID: 16208768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational and ion binding properties of a cyclic octapeptide, cyclo (Ala-Leu-Pro-Gly)2.
    Jois DS; Easwaran KR; Bednarek M; Blout ER
    Biopolymers; 1992 Aug; 32(8):993-1001. PubMed ID: 1420982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD, 1H NMR and molecular modeling studies of the interaction of Ca2+ with substance P and Ala7-substance P in a non-polar solvent.
    Qi XF; Zhorov BS; Ananthanarayanan VS
    J Pept Sci; 2000 Feb; 6(2):57-83. PubMed ID: 10718128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen-1 and carbon-13 magnetic resonance studies of nonactin-calcium complex.
    Vishwanath CK; Easwaran KR
    Biochemistry; 1981 Mar; 20(7):2018-23. PubMed ID: 6894386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location and ion-binding of membrane-associated valinomycin, a proton nuclear magnetic resonance study.
    Meers P; Feigenson GW
    Biochim Biophys Acta; 1988 Mar; 938(3):469-82. PubMed ID: 3349073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the lipid environment on valinomycin structure and cation complex formation.
    Halsey CM; Benham DA; JiJi RD; Cooley JW
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():200-6. PubMed ID: 22683555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valinomycin-proton interaction in low-polarity media.
    Kríz J; Dybal J; Makrlík E
    Biopolymers; 2006 Aug; 82(5):536-48. PubMed ID: 16538664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution solid-state 13C NMR study of free and metal-complexed macrocyclic antibiotic ionophores valinomycin, nonactin, and tetranactin: conformational elucidation in solid and solution by conformation-dependent 13C chemical shifts.
    Tabeta R; Saitô H
    Biochemistry; 1985 Dec; 24(26):7696-702. PubMed ID: 3841495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformations of an ion-binding cyclic peptide analogue of valinomycin, cyclo(L-Val-Gly-Gly-L-Pro)3.
    Easwaran KR; Pease LG; Blout ER
    Biochemistry; 1979 Jan; 18(1):61-7. PubMed ID: 420778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation of antibiotic X-537A (lasalocid-A) and its calcium complex in acetonitrile solvent using circular dichroism spectroscopy.
    Vishwanath CK; Easwaran KR
    FEBS Lett; 1983 Mar; 153(2):320-4. PubMed ID: 6617862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of oxytocin with Ca2+: II. Proton magnetic resonance and molecular modeling studies of conformations of the hormone and its Ca2+ complex.
    Ananthanarayanan VS; Belciug MP; Zhorov BS
    Biopolymers; 1996; 40(5):445-64. PubMed ID: 9062068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational studies of peptide cyclo-(D-Val-L-Pro-L-Val-D-Pro]3, a cation-binding analogue of valinomycin.
    Davis DG; Gisin BF; Tosteson DC
    Biochemistry; 1976 Feb; 15(4):768-74. PubMed ID: 1247533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of valinomycin and its potassium complex in homogeneous solvents.
    Forester TR; Smith W; Clarke JH
    Biophys J; 1996 Aug; 71(2):544-53. PubMed ID: 8842194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiroptic recognition of potassium ion.
    Wolfbeis OS; Opitz D; Werner T; Ouart A
    J Mol Recognit; 2001; 14(1):13-7. PubMed ID: 11180558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution and ion-complexed conformations of beauvericin determined by proton magnetic resonance spectroscopy.
    Khaled MA; Davies DB
    Biochim Biophys Acta; 1982 Jun; 704(2):186-96. PubMed ID: 6285981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the conformations of valinomycin in solution phase.
    Wang F; Zhao C; Polavarapu PL
    Biopolymers; 2004 Sep; 75(1):85-93. PubMed ID: 15307200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UVRR spectroscopic studies of valinomycin complex formation in different solvents.
    Ozdemir A; Lednev IK; Asher SA
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):19-26. PubMed ID: 15556416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.